Healthcare finance leaders can work with orthopedic surgeons to support better outcomes, clinically and financially, by: Establishing innovative partnerships among hospital leaders, orthopedic surgeons, and implant vendors. Developing and enforcing expectations around contracting and vendor behavior. Establishing a forum for open communication. Building a bundled payment structure. Finding ways...

he relationship of orthopedic surgeons to medical device companies has come under increasing scrutiny in recent months. A front-page article in the September 22, 2005, issue of The New York Times reported that a Louisiana orthopedic surgeon paid $10,000 in fines after state investigators determined that his consulting agreement with an implant manufacturer was an improper conflict of interest u...

Background: The incidence of placement of osteosynthetic materials has grown worldwide. Bioabsorbable materials are more commonly used now days in Orthopedic surgeries. Implants modify the risk of infection by bacterial adhesion, tissue integration, and immunomodulation. Bacterial adhesion to implant leads to interaction between bacteria and implant. Aim: To evaluate the incidence of infections...

Background The USA devotes roughly $200 billion (6%) of annual national health expenditures to medical devices. A substantial proportion of this spending occurs during orthopedic (eg, hip and knee) arthroplasties - two high-volume hospital procedures. The implants used in these procedures are commonly known as physician preference items (PPIs), reflecting the physician's choice of implant and v...

Despite the potential for growth factor delivery strategies to promote orthopedic implant healing, there is a need for growth factor delivery methods that are controllable and amenable to clinical translation. We have developed a modular bone growth factor, herein termed "modular bone morphogenetic peptide (mBMP)", which was designed to efficiently bind to the surface of orthopedic implants and...

It is expected that in future, there will be an immense usage of implantable devices which will cause the number of infections to increase naturally because some patients are unable to autonomously prevent formation of bio film on implant surfaces. The ideal implant should be able to promote osteointegration, deter bacterial adhesion and minimize prosthetic infection. Recent developments in mat...

With the rapid development of orthopedic implant technology, various bone implant surgeries and procedures (such as bone fractures, repairing defects, and hip and knee replacements) are routinely performed. Although these surgeries are usually successful operations for up to 15 years, implant failure due to loosening of the prostheses does occur for active or heavy patients. Other patients rece...

Orthopedic implants have revolutionized treatment of bone fractures and noninfectious joint arthritis. Today, the risk for orthopedic device-related infection (ODRI) is <1%-2%. However, the absolute number of patients with infection continuously increases as the number of patients requiring such implants grows. Treatment of ODRIs most frequently includes long-term antimicrobial treatment and re...

Submit Manuscript | http://medcraveonline.com model typically requires the surgical facility to manage implant inventory and own the surgical instrumentation associated with the orthopedic implant. There also exists a hybrid model that utilizes stable generic implants with a sales rep that consigns instrumentation and manages his inventory. The purpose of this study was to compare surgical supp...